Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mimedx (MDXG) Assets (2016 - 2025)

Historic Assets for Mimedx (MDXG) over the last 16 years, with Q3 2025 value amounting to $319.0 million.

  • Mimedx's Assets rose 3079.12% to $319.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $319.0 million, marking a year-over-year increase of 3079.12%. This contributed to the annual value of $263.9 million for FY2024, which is 1040.3% up from last year.
  • As of Q3 2025, Mimedx's Assets stood at $319.0 million, which was up 3079.12% from $291.1 million recorded in Q2 2025.
  • In the past 5 years, Mimedx's Assets registered a high of $319.0 million during Q3 2025, and its lowest value of $168.2 million during Q1 2023.
  • For the 5-year period, Mimedx's Assets averaged around $213.0 million, with its median value being $189.0 million (2023).
  • Its Assets has fluctuated over the past 5 years, first crashed by 1537.61% in 2021, then soared by 3944.29% in 2023.
  • Mimedx's Assets (Quarter) stood at $187.9 million in 2021, then decreased by 8.78% to $171.4 million in 2022, then soared by 39.44% to $239.0 million in 2023, then rose by 10.4% to $263.9 million in 2024, then increased by 20.87% to $319.0 million in 2025.
  • Its Assets stands at $319.0 million for Q3 2025, versus $291.1 million for Q2 2025 and $270.4 million for Q1 2025.